July 4 (Reuters) - Cyclopharm Ltd (CYC) :
- 1H 2022 BUSINESS UPDATE - RECORD REVENUES
- SEES 1H FY 2022 TOTAL UNAUDITED GROUP SALES REVENUE TO BE ABOUT A$11.3 MILLION
- NET CASH POSITION AT HALF YEAR EXPECTED TO BE A$26 MILLION
- 1H FY 2022 REVENUES FROM PREDOMINANTLY RECURRING PATIENT ADMINISTRATION SETS CONSUMABLES EXPECTED TO BE 21% HIGHER THAN PCP
News: CYC Cyclopharm Says Expects 1H FY 2022 Total Unaudited Group Sales Revenue To Be About A$11.3...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
77.0¢ |
Change
-0.070(8.33%) |
Mkt cap ! $85.57M | |||
| Open | High | Low | Value | Volume |
| 84.0¢ | 84.0¢ | 75.5¢ | $160.3K | 200.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2999 | 77.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2025 (20 minute delay) ? |
| CYC (ASX) Chart |